EGFR and lung adenocarcinoma: The incidence of brain metastasis (BM) in patients with NSCLC can reach up to 50%, with the highest incidence of BM in cases of epidermal growth factor receptor-positive lung adenocarcinoma (LA-EGFRp) at approximately 45–52% [5, 6].